Home About Latest Browse RSS Advanced Search

Federal Reserve Bank of New York
Staff Reports
What do drug monopolies cost consumers in developing countries?
Rebecca Hellerstein
Abstract

This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.


Download Full text
Download Full text
Cite this item
Rebecca Hellerstein, What do drug monopolies cost consumers in developing countries?, Federal Reserve Bank of New York, Staff Reports 530, 2011.
More from this series
JEL Classification:
Subject headings:
Keywords: Pharmaceutical industry ; Drugs ; Prices ; Developing countries
For corrections, contact Amy Farber ()
Fed-in-Print is the central catalog of publications within the Federal Reserve System. It is managed and hosted by the Economic Research Division, Federal Reserve Bank of St. Louis.

Privacy Legal